Aap Implantate AG Extends CEO Tenure and Announces COO Departure

aap Implantate AG has confirmed that Rubino Di Girolamo will continue as CEO until the end of 2028. Di Girolamo, who has been leading the company since 2019, is focused on advancing aap's transformation and strategic goals. He aims to position aap's antibacterial platform coating technology as a key player in the trauma market.

The company is anticipating pivotal milestones, including the launch of its first silver products and a strategic realignment. This transformational process is projected to span two to three years. Di Girolamo is committed to guiding aap through these developments to secure its future.

Concurrently, COO Agnieszka Mierzejewska will leave aap at the end of 2025, intending to explore new professional opportunities after over a decade with the company. She has played a crucial role in the company's operational growth and stability. The Supervisory Board expressed appreciation for her contributions and extends best wishes for her future endeavors.